STING1 and neoplasm: This activates the cyclic GMP‐AMP synthase (cGAS)‐stimulator of the IFN gene (STING) signaling pathway, thereby enhancing anti‐tumor immunotherapy through dendritic cell‐T cell‐dependent functions.